The Sudden Cardiac Arrest Foundation is dedicated to bringing you the latest news and developments in sudden cardiac arrest prevention and treatment.

Johnnie's story

Johnnie Davis is an inspirational speaker, best-selling author, entrepreneur, and success coach. His book I'm Still Here: From Heart Failure to Heart of A Champion is a #1 Amazon Best Seller. He is also one of 25 co-authors of the book Cardiac Athletes, also available on Amazon. Johnnie is a heart failure and sudden cardiac arrest survivor with an… Read More

Shortage of AEDs and other medical devices a potentially life-threatening issue for patients, says GlobalData

The recent news that automated external defibrillators (AEDs) including wearable and nonwearable versions, chest drains/ suction canisters and autotransfusion systems have been added to the list of medical devices in short supply by the Food and Drug Administration (FDA) on July 20, 2022, is a very real and potentially life-threatening issue for… Read More

Scientists to rewrite DNA to cure killer heart diseases 

British Heart Foundation to award £30m in “defining moment” for cardiovascular medicine An injectable cure for inherited heart muscle conditions that can kill young people in the prime of their lives could be available within a few years, after an international team of researchers were announced as the winners of the British Heart Foundation’s… Read More

Main Line Health, Mayo researchers find natural product may prevent sudden cardiac death from rare inherited syndromes

In 2020, a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, used experimental models to discover that a natural product found in plants including safflower holds promise for treating a pair of hereditary sudden cardiac death syndromes.  Now, collaborators from LIMR and Mayo Clinic … Read More

Accessible defibrillators in schools could treat two thirds of out of hospital cardiac arrests

A study from the University of Warwick has found that school-based defibrillators (AEDs) that are accessible outside of school hours could be effective in treating over two thirds of Out of Hospital Cardiac Arrests (OHCAs) within five minutes. Over half of schools responding to a survey in the West Midlands have a defibrillator (AED), but the… Read More

Defibrillators added to FDA’s list of device shortages

The AED supply disruption reflects both surging demand and problems sourcing a component, part or accessory. The FDA has added automated external defibrillators (AEDs) to its list of medical devices in short supply. AEDs — including wearable and nonwearable versions of the devices — are expected to be in limited supply for at least the rest of… Read More

How AI is changing the world of defibrillators

Success rate has improved but cost and high processing power are concerns Defibrillators are used to deliver electrical currents to the heart as treatment for cardiac arrest that can potentially be fatal. AI is making a big impact on how defibrillators can work more efficiently, with machine learning algorithms becoming increasingly accurate with… Read More

Adrenaline shot can save lives after heart stops, but at a heavy price

An adrenaline shot can restart your heart if it suddenly stops beating, but a new trial shows that chances are you might not return to much of a life if you survive. People who suffered cardiac arrest and were resuscitated with adrenaline had an almost doubled risk of severe brain damage, researchers found. "We found adrenaline does not increase… Read More

New Colorado office to collect cardiac arrest data to improve survivability

Local individuals, organizations played vital role in establishing the office On June 1, 2022, Colorado became the first state to establish an office exclusively dedicated to saving people who experience cardiac arrest. House Bill 22-1251, sponsored by Rep. Dylan Roberts and Sen. Jeff Bridges, took effect on July 1 and established the Office of… Read More

Renovacor announces pipeline expansion with new research program for multiple genetic segments of arrhythmogenic cardiomyopathy

Research collaboration with the University of Utah's Nora Eccles Harrison Cardiovascular Research and Training Institute expands pipeline with the addition of an AAV gene therapy program for multiple genetic segments of arrhythmogenic cardiomyopathy CAMBRIDGE, MA -- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering… Read More